daunorubicin has been researched along with Glucosephosphate Dehydrogenase Deficiency in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Efferth, T; Fabry, U; Glatte, P; Osieka, R | 1 |
| Amitai, Y; Bhooma, T; Frischer, H | 1 |
| Collins, RD; Lukens, JN; Roloff, JS | 1 |
3 other study(ies) available for daunorubicin and Glucosephosphate Dehydrogenase Deficiency
| Article | Year |
|---|---|
Increased induction of apoptosis in mononuclear cells of a glucose-6-phosphate dehydrogenase deficient patient.
Topics: Adult; Apoptosis; Daunorubicin; Dexamethasone; DNA; Flow Cytometry; Glucosephosphate Dehydrogenase Deficiency; Glutathione; Humans; Leukocytes, Mononuclear; Radiation, Ionizing | 1995 |
Glucose-6-phosphate dehydrogenase deficiency severely restricts the biotransformation of daunorubicin in human erythrocytes.
Topics: Adult; Alcohol Oxidoreductases; Binding, Competitive; Biotransformation; Daunorubicin; Doxorubicin; Erythrocytes; Glucosephosphate Dehydrogenase Deficiency; Humans; Primaquine | 1996 |
Multiple thromboemboli.
Topics: Child; Daunorubicin; Female; Glucosephosphate Dehydrogenase Deficiency; Humans; Leukemia, Lymphoid; Thromboembolism | 1978 |